These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8075982)

  • 21. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
    Chong P; Cockle S; Boux H; Klein M
    Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis toxin has eukaryotic-like carbohydrate recognition domains.
    Saukkonen K; Burnette WN; Mar VL; Masure HR; Tuomanen EI
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):118-22. PubMed ID: 1729677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning of pertussis toxin genes.
    Locht C; Barstad PA; Coligan JE; Mayer L; Munoz JJ; Smith SG; Keith JM
    Nucleic Acids Res; 1986 Apr; 14(8):3251-61. PubMed ID: 2871544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lectin domains in the toxin of Bordetella pertussis: selectin mimicry linked to microbial pathogenesis.
    Sandros J; Rozdzinski E; Zheng J; Cowburn D; Tuomanen E
    Glycoconj J; 1994 Dec; 11(6):501-6. PubMed ID: 7535138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ins and outs of pertussis toxin.
    Locht C; Coutte L; Mielcarek N
    FEBS J; 2011 Dec; 278(23):4668-82. PubMed ID: 21740523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of Pertussis toxin subunits.
    Sheu GC; Wo YY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
    Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
    Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.
    van't Wout J; Burnette WN; Mar VL; Rozdzinski E; Wright SD; Tuomanen EI
    Infect Immun; 1992 Aug; 60(8):3303-8. PubMed ID: 1353482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
    Ben-Nun A; Mendel I; Kerlero de Rosbo N
    Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NAD-glycohydrolase activity of the pertussis toxin S1 subunit. Involvement of the catalytic HIS-35 residue.
    Antoine R; Locht C
    J Biol Chem; 1994 Mar; 269(9):6450-7. PubMed ID: 8119996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis.
    Runeberg-Nyman K; Engström O; Löfdahl S; Ylöstalo S; Sarvas M
    Microb Pathog; 1987 Dec; 3(6):461-8. PubMed ID: 2904640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and secretion of pertussis toxin subunits in Bacillus subtilis.
    Saris P; Taira S; Airaksinen U; Palva A; Sarvas M; Palva I; Runeberg-Nyman K
    FEMS Microbiol Lett; 1990 Mar; 56(1-2):143-8. PubMed ID: 2110091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.
    Stein PE; Boodhoo A; Tyrrell GJ; Brunton JL; Read RJ
    Nature; 1992 Feb; 355(6362):748-50. PubMed ID: 1741063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and immunological properties of the five subunits of pertussis toxin.
    Nicosia A; Bartoloni A; Perugini M; Rappuoli R
    Infect Immun; 1987 Apr; 55(4):963-7. PubMed ID: 3549567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
    Schmidt MA; Schmidt W
    Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophobic binding of pertussis toxin is enhanced by oligosaccharide receptors.
    Spangler BD; Heerze LD; Clark CG; Armstrong GD
    Arch Biochem Biophys; 1993 Aug; 305(1):153-8. PubMed ID: 7688202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.